CollPlant Biotechnologies Ltd. (CLGN) released Loss for third quarter of -$3.483 million
The company's bottom line came in at -$3.483 million, or -$0.27 per share. This compares with -$4.326 million, or -$0.38 per share, last year.
Excluding items, CollPlant Biotechnologies Ltd. reported adjusted earnings of -$3.160 million or -$0.25 per share for the period.
The company's revenue for the period rose 1825.0% to $0.077 million from $0.004 million last year.
CollPlant Biotechnologies Ltd. earnings at a glance (GAAP) :
-Earnings: -$3.483 Mln. vs. -$4.326 Mln. last year.-EPS: -$0.27 vs. -$0.38 last year.-Revenue: $0.077 Mln vs. $0.004 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.